Senetek PLC Announces Positive Results From Pyratine-6(TM) Clinical Trial In Patients With Acne Rosacea

May 06th, 2008 | Category: Dermatology

Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, announced positive study results from a clinical trial of Pyratine-6(TM) in patients with acne

rosacea. The findings have been accepted for presentation at the universal Investigative Congress of Dermatology at its May 2008 meeting in Kyoto, Japan.

Original post by Women’s Health / Gynecology News From Medical News Today

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Netvouz
  • DZone
  • ThisNext
  • MisterWong
  • Wists
  • BlinkList
  • Furl
  • IndianPad
  • Netscape
  • Reddit
  • Simpy
  • Spurl
  • StumbleUpon
  • Technorati
Related Articles
  • Senetek PLC Announces Debut Of Pyratine-6(TM) At The Annual Meeting Of The American Academy Of Dermatology
  • Acne Rosacea Affects Millions Worldwide - Many Don’t Know They Have It
  • Cutanea Announces Promising Phase II Results In Rosacea With Omiganan
  • Scientists Discover Clues To Rosacea Skin Ailment
  • Acne And Rosacea Getting You Down? Laser, Light And Cosmetic Treatments Give Patients A Much Needed Boost

    • No comments yet. Be the first.

    Leave a reply

    You must be logged in to post a comment.